Learn About Smoldering Multiple Myeloma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
The Frederick Ferris Thompson Hospital
Paul Hosking is a Hematologist and a Hematologist Oncology provider in Canandaigua, New York. Dr. Hosking has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Smoldering Multiple Myeloma, Multiple Myeloma, Schnitzler Syndrome, and Monoclonal Gammopathy of Undetermined Significance (MGUS).
Auburn Community Hospital
Sam Benjamin is an Oncologist in Auburn, New York. Dr. Benjamin and is rated as an Experienced provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Choriocarcinoma, Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Thyroidectomy.
Auburn Community Hospital
Sarah Bradford is a Nurse Practitioner in Auburn, New York. Bradford has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer and Smoldering Multiple Myeloma. Bradford is currently accepting new patients.
Summary: The purpose of this study is to see whether combination treatment of Teclistamab and Daratumumab (Tel-Dara) or combination Talquetamab and Daratumumab (Tal-Dara) will delay the onset of multiple myeloma.
Summary: The purpose of this study is to identify multiple myeloma in the precancerous MGUS stage in order to reduce the risk of delayed diagnosis of multiple myeloma, decrease morbidity related to multiple myeloma at progression, and improve long term outcomes.